ANGIOTENSIN TYPE-1 RECEPTOR AND ACE2 AUTOANTIBODIES IN PARKINSON´S DISEASE

• Ana Isabel Rodríguez Pérez,
• Carmen M Labandeira,
• María A Pedrosa,
• Aloia Quijano,
• Rita Valenzuela,
• Pablo Garrido-Gil,
• Mariña Sanchez-Andrade,
• Juan Antonio Suárez-Quintanilla,
• José Luis Labandeira-García

Affiliations

Ana Isabel Rodríguez Pérez

Research Center for Molecular Medicine and Chronic diseases (CIMUS), Idis, University Of Santiago De Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases, Ciberned, Madrid, Spain

Carmen M Labandeira

Research Center for Molecular Medicine and Chronic diseases (CIMUS), Idis, University Of Santiago De Compostela, Santiago de Compostela, Spain; Hospital Alvaro Cunqueiro, University Hospital Complex, Clinical Neurology, Vigo, Spain; University Hospital of Ourense, Clinical Neurology, Ourense, Spain

María A Pedrosa

Research Center for Molecular Medicine and Chronic diseases (CIMUS), Idis, University Of Santiago De Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases, Ciberned, Madrid, Spain

Aloia Quijano

Research Center for Molecular Medicine and Chronic diseases (CIMUS), Idis, University Of Santiago De Compostela, Santiago de Compostela, Spain

Rita Valenzuela

Research Center for Molecular Medicine and Chronic diseases (CIMUS), Idis, University Of Santiago De Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases, Ciberned, Madrid, Spain

Pablo Garrido-Gil

Research Center for Molecular Medicine and Chronic diseases (CIMUS), Idis, University Of Santiago De Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases, Ciberned, Madrid, Spain

Mariña Sanchez-Andrade

University Clinical Hospital of Santiago de Compostela, Obstetric Service, Santiago de Compostela, Spain

Juan Antonio Suárez-Quintanilla

Primary Health-Care Unit Fontiñas, Idis, Santiago de Compostela, Spain

José Luis Labandeira-García

Research Center for Molecular Medicine and Chronic diseases (CIMUS), Idis, University Of Santiago De Compostela, Santiago de Compostela, Spain; Networking Research Center on Neurodegenerative Diseases, Ciberned, Madrid, Spain